Please provide your email address to receive an email when new articles are posted on . FibroTest showed low accuracy in detecting significant fibrosis and cirrhosis among patients with chronic ...

Please provide your email address to receive an email when new articles are posted on . Poynard and colleagues studied 600 patients who recently had bloodwork and biopsies and were likely to have ...

In recent years the use of non-invasive biomarkers to assess liver fibrosis has become widely accepted. Although the combination of surrogate markers, such as those employed by the FibroTest, have a ...

Background: FibroTest (FT) is a biomarker of liver fibrosis initially validated in patients with chronic hepatitis C (CHC). The aim was to test two hypotheses, one, that the FT diagnostic value was ...

Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin).

Disease etiology is a major factor in the performance of noninvasive fibrosis biomarkers, according to new research published in Alimentary Pharmacology & Therapeutics. Moreover, the findings from ...